We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AM icon
1601
Antero Midstream
AM
$10.1B
$254K 0.01%
28,055
+20,177
+256% +$210K
FMS icon
1602
Fresenius Medical Care
FMS
$12.9B
$254K 0.01%
10,191
+7,733
+315% +$231K
IHF icon
1603
iShares US Healthcare Providers ETF
IHF
$1.27B
$254K 0.01%
+4,970
New +$265K
RLAY icon
1604
Relay Therapeutics
RLAY
$4.33B
$254K 0.01%
15,181
+12,473
+461% +$267K
SPXS icon
1605
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$332M
$254K 0.01%
955
-29,201
-97% -$6.63M
Z icon
1606
Zillow
Z
$7.56B
$254K 0.01%
7,972
-18,947
-70% -$761K
ERF
1607
DELISTED
Enerplus Corporation
ERF
$254K 0.01%
19,260
-20,974
-52% -$289K
ARQT icon
1608
Arcutis Biotherapeutics
ARQT
$3.18B
$253K 0.01%
11,877
+11,018
+1,283% +$226K
SPB icon
1609
Spectrum Brands
SPB
$2.07B
$253K 0.01%
3,088
-7,689
-71% -$660K
ICHR icon
1610
Ichor Holdings
ICHR
$2.56B
$252K 0.01%
9,699
+9,349
+2,671% +$271K
RVLV icon
1611
Revolve Group
RVLV
$1.73B
$252K 0.01%
9,743
+2,814
+41% +$104K
VNDA icon
1612
Vanda Pharmaceuticals
VNDA
$302M
$252K 0.01%
23,124
+15,356
+198% +$159K
DSGX icon
1613
Descartes Systems
DSGX
$6.82B
$251K 0.01%
4,041
+3,495
+640% +$218K
CXT icon
1614
Crane NXT
CXT
$3.07B
$250K 0.01%
8,211
+1,290
+19% +$42.9K
TKR icon
1615
Timken Company
TKR
$9.03B
$250K 0.01%
4,728
+2,611
+123% +$152K
WAFD icon
1616
WaFd
WAFD
$2.75B
$250K 0.01%
8,326
+6,948
+504% +$218K
VGR
1617
DELISTED
Vector Group Ltd.
VGR
$250K 0.01%
23,834
+20,821
+691% +$250K
AVNT icon
1618
Avient
AVNT
$4.19B
$249K 0.01%
6,221
+4,338
+230% +$205K
HSTM icon
1619
HealthStream
HSTM
$840M
$249K 0.01%
11,427
+11,017
+2,687% +$220K
RYAAY icon
1620
Ryanair
RYAAY
$31.3B
$249K 0.01%
9,260
+5,895
+175% +$198K
UMBF icon
1621
UMB Financial
UMBF
$11.1B
$249K 0.01%
2,893
+1,988
+220% +$180K
FTC icon
1622
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.38B
$248K 0.01%
2,815
-2,986
-51% -$286K
PENN icon
1623
PENN Entertainment
PENN
$2.71B
$246K 0.01%
8,087
-22,127
-73% -$747K
SKF icon
1624
ProShares UltraShort Financials
SKF
$10.6M
$246K 0.01%
2,683
-411
-13% -$32.9K
SNV
1625
DELISTED
Synovus
SNV
$246K 0.01%
6,834
-4,795
-41% -$198K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.